DEA Denies Registration Over Drug-Related Convictions
Published Date: 7/10/2026
Notice
Summary
Ruth Jones, D.O., tried to get a DEA registration but was denied because she was convicted of serious drug-related crimes and banned from federal health programs. She missed the deadline to ask for a hearing, so the case was closed against her. This means she can’t legally handle controlled substances, affecting her medical practice and career.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
DEA Registration Denied Effective Aug 10, 2026
The DEA denied Ruth Jones, D.O.'s pending application for a DEA Certificate of Registration (Control No. W23004273C) and also denied any other pending application of hers for additional registration in Pennsylvania. The Order is effective August 10, 2026.
Existing HHS/OIG Exclusion Confirmed
The record shows the U.S. Department of Health and Human Services, Office of Inspector General mandatorily excluded Ruth Jones from Medicare, Medicaid, and all federal health care programs effective July 20, 2022, for a minimum period of five years. The DEA relied on that exclusion in denying her registration under 21 U.S.C. 824(a)(5).
Missed Hearing Request Causes Default
Because the applicant did not timely file a request for hearing after the DEA's Order to Show Cause, she was deemed in default and the factual allegations in the OSC were admitted. The DEA sought final agency action based on that default, and the Chief ALJ terminated proceedings for untimeliness.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-17276, Importer of Controlled Substances Application: Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
2026-17285, Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
2026-17275, Catina Allen, N.P.; Decision and Order
Catina Allen, a nurse practitioner from Indiana, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration, which expired on June 30, 2026. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
2026-16665, Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through June 30, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
Previous / Next Documents
Previous: 2026-13990, Mariana Moualem, F.N.P.; Decision and Order
Mariana Moualem, a nurse practitioner from California, lost her DEA registration because she no longer has the state permission to handle controlled substances. She didn’t ask for a hearing to fight this, so the DEA moved forward and officially revoked her registration. This means she can’t legally prescribe or handle certain drugs anymore, effective immediately, with no money penalties mentioned.
Next: 2026-13992, Timothy Genetta, D.O.; Decision and Order
Dr. Timothy Genetta from Ohio lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he must stop prescribing or handling these drugs immediately, with no money or timing benefits for him.